Carlsmed, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Carlsmed, Inc. | CARL - NASDAQ |
$14.00-$16.00 | $15.00 | $15.00 | 6.7 million | 7/23/2025 |
| BofA Securities, Goldman Sachs, Piper Sandler | ||||||
Co-Manager(s): Truist Securities, BTIG | ||||||
| Health Care | ||||||
Filing(s): Filed 2025-06-26 Terms Added 2025-07-15 | ||||||
Carlsmed, Inc. Quote & Chart - Click for current quote - CARL
IPO Boutique aggregates information on public companies and private companies, such as "CARL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Carlsmed, Inc. (adapted from Carlsmed, Inc. prospectus):
They are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CARL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.